Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy. [PDF]
, 2011 Our study shows that in Indonesian cancer patients treated with highly cytostatic emetogenic, carriership of the CTG haplotype of the ABCB1 gene is related to an increased risk of delayed chemotherapy-induced nausea and ...
Baak-Pablo, Renee F +8 more
core +4 more sources
Clinical Parkinsonism & Related Disorders, 2023 Introduction: Pretreatment with the antiemetic trimethobenzamide has been recommended practice in the United States (US) to address the risk of nausea and vomiting during initiation of apomorphine treatment.
Stuart H. Isaacson +3 more
doaj +2 more sources
Impact of antiemetic steroid use on survival in small cell lung cancer patients receiving immune checkpoint inhibitors and chemotherapy [PDF]
Scientific ReportsImmune checkpoint inhibitors (ICIs) combined with conventional cytotoxic agents have become the new standard of care for extensive-stage small cell lung cancer (SCLC).
Soh Mee Park +3 more
doaj +2 more sources
Efficacy of intraoperative low-dose remimazolam as a third antiemetic agent for preventing early postoperative nausea in high-risk patient: A Randomized controlled trial. [PDF]
BMC AnesthesiolPark S, Yon JH, Lee S, Kim KM, Jun IJ.
europepmc +3 more sources
Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine [PDF]
Archives of Razi Institute, 2021 Substance P binds to the Neurokinin-1 (NK-1) receptors found in the emetic center of the central nervous system (CNS) to induce emesis. Maropitant is a selective NK-1 receptor antagonist that inhibits the binding of substance P to NK-1 receptors and is ...
K Sharun +7 more
doaj +1 more source
Tratamiento de la emesis inducida por citotóxicos [PDF]
Psicooncologia, 2004 Nausea and vomiting are important side effects of most chemotherapy anticancer drugs, since nearly two thirds of the patients under chemotherapy have this toxicity in absence of antiemetic treatment.
Miguel Martín, Sara López
doaj +2 more sources
Use of Coca-Cola drinks in gastric pathology in pediatric patients [PDF]
Romanian Journal of Pediatrics, 2020 Facing us the relatively frequent tendency of many people – medical professionals or not – to administer Coca-Colatype carbonated beverages in the case of nausea-type gastric symptoms or vomiting in pediatric or adult patients, we have tried to ...
Cristina Munteanu
doaj +1 more source
Utilizarea băuturilor de tip Coca-Cola în patologia gastrică la pacienţii pediatrici [PDF]
Romanian Journal of Pediatrics, 2020 În faţa tendinţei relativ frecvente a multor persoane – cadre medicale sau nu – de a administra băuturi carbogazoase de tipul Coca-Cola în cazul unor simptome gastrice de tip greaţă sau vărsături la pacienţii pediatrici sau adulţi, am încercat să ...
Cristina Munteanu
doaj +1 more source
Frontiers in Public Health, 2022 ObjectiveThe purpose of this study was to evaluate the cost-effectiveness and budget impact of fosaprepitant (FosAPR)-containing regimen for the prevention of chemotherapy-induced nausea and vomiting (CINV) among patients receiving high emetogenic ...
Xinglu Xu +7 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Temsirolimus is a prodrug form of sirolimus (rapamycin). With its analogs (everolimus, ridaforolimus, and rapamycin), it forms a group of anticancer agents that block the activity of one of the two mammalian targets of rapamycin (mTOR) complexes, mTORC1.
Louiza Belkacemi +2 more
doaj +1 more source